Polymorphisms affecting various genes, such as angiotensin converting enzyme (ACE), thrombin-activatable fibrinolysis inhibitor (TAFI), and nitric oxide synthase (NOS) genes, as suggested by recent advances in genetic research techniques are associated with the incidence of ischemic stroke (3–9). The gene discussed is ACE; the disease is ischemic stroke.